* Cytori announces enrollment completion in U.S. Phase III
scleroderma trial
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
The post BRIEF-Cytori completes enrollment in U.S. phase III scleroderma trial appeared first on NASDAQ.